Brinton triples production of COVID-19 drug Favipiravir

Brinton triples production of COVID-19 drug Favipiravir

By: IPP Bureau

Last updated : June 08, 2021 11:19 am



Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases


Brinton Pharmaceuticals, has more than tripled the production of COVID-19 drug Faviton (Favipiravir 400) tablet, used as an oral antiviral therapy for mild to moderate cases of COVID-19. 

Brinton Pharmaceuticals has also increased the production of additional drugs Scabover & Iverbond (Ivermectin 12 mg) Tablet and Doxybond LB & Briodox (Doxycycline) Tablet which are also used towards the treatment of COVID-19. 

If taken at the right time under medical supervision, Faviton helps cut down the trips to the hospital if the patient has mild and moderate symptoms. 

This decision comes at a time where people are finding it hard to find hospital beds for their loved ones and more deaths are being seen because hospitals don’t have enough oxygen supply. Patients are also facing shortages of these medicines that are crucial to treat the virus. At a time like this, Brinton’s call to increase production from 15 lakh to 50 lakh quantity, and will further continue to increase the production of its crucial medicines to help save many lives. 

Moreover, Brinton is providing Faviton at MRP of Rs. 790/10 tablets thereby further helping patients and their families. 

Rahul Darda, CMD, Brinton Pharmaceuticals said, “We are saddened by the way the country is battling the present wave. The end consumer or patient should be least worried about these matters and should only focus on getting better. Towards trying to improve the situation, we wanted to do our bit. By taking this call of tripling up production we will be able to help the end patient by getting the medicine available easily. We hope this helps the masses at large.” 

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases. Brinton had launched Favipiravir in May 2020 in light of the COVID-19 pandemic.

Brinton Pharmaceuticals Favipiravir Remdesivir Rahul Darda

First Published : May 12, 2021 12:00 am